Second Line Treatment of Non-Small Cell Lung Cancer: Clinical; Pathological and Molecular Aspects of Novel Promising Drugs

• Yazar: Umberto Malapelle (auth)
• Diğer Yazarlar: Pierlorenzo Pallante (auth)
• Materyal Türü: Elektronik Kitap Bölümü
• Dil: İngilizce
• Baskı/Yayın Bilgisi: Frontiers Media SA 2017
• Seri Bilgileri: Frontiers Research Topics
• Konular: Medicine; Alectinib; Liquid Biopsy; Non-Small Cell Lung Cancer; Afatinib; Nivolumab; Immunotherapy; Nintedanib; Dacomitinib; Second-Line Treatment; Tyrosine Kinase Inhibitor
• Online Erişim: DOAB: download the publication; DOAB: description of the publication

Lung cancer still remains a challenging disease with a higher mortality rate in comparison to other cancers. The discovery of oncogene addicted tumours and targeted therapies responsive to these targets lead to a meaningful change in the prognosis of these diseases. Unfortunately, these newer therap...